Prophylactic regimens to prevent mother-to-child transmission of HIV and their effect on future therapy

James McIntyre, Neil Martinson

Research output: Contribution to journalArticle

Abstract

The use of combination antiretroviral treatment for the prevention of mother-to-child transmission (PMTCT) of HIV has been extremely successful in reducing pediatric HIV infection and is the standard of care in well-resourced settings. In most high-prevalence, less-resourced settings, short-course, single or combination antiretroviral regimens have been the only available PMTCT interventions. Concerns have emerged around the potential impact of viral resistance selected following the use of nevirapine as single-dose or in short-course combination regimens, and the use of lamivudine in short-course dual therapy regimens. Early data have suggested a reduced response to non-nucleoside reverse transcriptase inhibitor-containing treatment regimens where these are started less than 6 months after pregnancy exposure to nevirapine, but no difference in clinical or virologic outcome if initiated more than 6 months after this PMTCT exposure. Treatment response to lamivudine-containing regimens may be diminished following nonsuppressive zidovudine and lamivudine combination PMTCT regimens.

Original languageEnglish (US)
Pages (from-to)797-805
Number of pages9
JournalTherapy
Volume4
Issue number6
DOIs
StatePublished - Nov 2007

Fingerprint

Lamivudine
Mothers
HIV
Nevirapine
Reverse Transcriptase Inhibitors
Zidovudine
Therapeutics
Standard of Care
HIV Infections
Pediatrics
Pregnancy

Keywords

  • Antiretroviral therapy
  • HIV
  • Lamivudine
  • Mother-to-child transmission
  • Nevirapine
  • PMTCT
  • Pregnancy
  • Resistance
  • Women

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Prophylactic regimens to prevent mother-to-child transmission of HIV and their effect on future therapy. / McIntyre, James; Martinson, Neil.

In: Therapy, Vol. 4, No. 6, 11.2007, p. 797-805.

Research output: Contribution to journalArticle

McIntyre, James ; Martinson, Neil. / Prophylactic regimens to prevent mother-to-child transmission of HIV and their effect on future therapy. In: Therapy. 2007 ; Vol. 4, No. 6. pp. 797-805.
@article{e34b7d053eb84a16823c2abf2ea2db1c,
title = "Prophylactic regimens to prevent mother-to-child transmission of HIV and their effect on future therapy",
abstract = "The use of combination antiretroviral treatment for the prevention of mother-to-child transmission (PMTCT) of HIV has been extremely successful in reducing pediatric HIV infection and is the standard of care in well-resourced settings. In most high-prevalence, less-resourced settings, short-course, single or combination antiretroviral regimens have been the only available PMTCT interventions. Concerns have emerged around the potential impact of viral resistance selected following the use of nevirapine as single-dose or in short-course combination regimens, and the use of lamivudine in short-course dual therapy regimens. Early data have suggested a reduced response to non-nucleoside reverse transcriptase inhibitor-containing treatment regimens where these are started less than 6 months after pregnancy exposure to nevirapine, but no difference in clinical or virologic outcome if initiated more than 6 months after this PMTCT exposure. Treatment response to lamivudine-containing regimens may be diminished following nonsuppressive zidovudine and lamivudine combination PMTCT regimens.",
keywords = "Antiretroviral therapy, HIV, Lamivudine, Mother-to-child transmission, Nevirapine, PMTCT, Pregnancy, Resistance, Women",
author = "James McIntyre and Neil Martinson",
year = "2007",
month = "11",
doi = "10.2217/14750708.4.6.797",
language = "English (US)",
volume = "4",
pages = "797--805",
journal = "Therapy",
issn = "2044-9038",
publisher = "Future Medicine Ltd.",
number = "6",

}

TY - JOUR

T1 - Prophylactic regimens to prevent mother-to-child transmission of HIV and their effect on future therapy

AU - McIntyre, James

AU - Martinson, Neil

PY - 2007/11

Y1 - 2007/11

N2 - The use of combination antiretroviral treatment for the prevention of mother-to-child transmission (PMTCT) of HIV has been extremely successful in reducing pediatric HIV infection and is the standard of care in well-resourced settings. In most high-prevalence, less-resourced settings, short-course, single or combination antiretroviral regimens have been the only available PMTCT interventions. Concerns have emerged around the potential impact of viral resistance selected following the use of nevirapine as single-dose or in short-course combination regimens, and the use of lamivudine in short-course dual therapy regimens. Early data have suggested a reduced response to non-nucleoside reverse transcriptase inhibitor-containing treatment regimens where these are started less than 6 months after pregnancy exposure to nevirapine, but no difference in clinical or virologic outcome if initiated more than 6 months after this PMTCT exposure. Treatment response to lamivudine-containing regimens may be diminished following nonsuppressive zidovudine and lamivudine combination PMTCT regimens.

AB - The use of combination antiretroviral treatment for the prevention of mother-to-child transmission (PMTCT) of HIV has been extremely successful in reducing pediatric HIV infection and is the standard of care in well-resourced settings. In most high-prevalence, less-resourced settings, short-course, single or combination antiretroviral regimens have been the only available PMTCT interventions. Concerns have emerged around the potential impact of viral resistance selected following the use of nevirapine as single-dose or in short-course combination regimens, and the use of lamivudine in short-course dual therapy regimens. Early data have suggested a reduced response to non-nucleoside reverse transcriptase inhibitor-containing treatment regimens where these are started less than 6 months after pregnancy exposure to nevirapine, but no difference in clinical or virologic outcome if initiated more than 6 months after this PMTCT exposure. Treatment response to lamivudine-containing regimens may be diminished following nonsuppressive zidovudine and lamivudine combination PMTCT regimens.

KW - Antiretroviral therapy

KW - HIV

KW - Lamivudine

KW - Mother-to-child transmission

KW - Nevirapine

KW - PMTCT

KW - Pregnancy

KW - Resistance

KW - Women

UR - http://www.scopus.com/inward/record.url?scp=38049105477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38049105477&partnerID=8YFLogxK

U2 - 10.2217/14750708.4.6.797

DO - 10.2217/14750708.4.6.797

M3 - Article

AN - SCOPUS:38049105477

VL - 4

SP - 797

EP - 805

JO - Therapy

JF - Therapy

SN - 2044-9038

IS - 6

ER -